ArticleThe Lancet regional health. Southeast Asia2024

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.

Mangaiarkarasi S Asokan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.